Scope Fluidics SA (SCP) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

PLN 396 Million ()

P/E

8.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.85

Return on Equity

46.04%

Price to Book

3.43

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Mar 2025)

Net Profit:

-11 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-7.83%

6 Months

-4.65%

1 Year

-4.14%

2 Years

-24.02%

3 Years

-29.43%

4 Years

7.49%

5 Years

-2.97%

Scope Fluidics SA for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

11.46%

EBIT Growth (5y)

-218.59%

EBIT to Interest (avg)

-20.20

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.94

Sales to Capital Employed (avg)

0.00

Tax Ratio

23.39%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

28.67%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.84

EV to EBIT

-10.32

EV to EBITDA

-10.85

EV to Capital Employed

23.15

EV to Sales

376.88

PEG Ratio

0.03

Dividend Yield

ROCE (Latest)

-224.36%

ROE (Latest)

45.73%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 0.00% vs -100.00% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is -61.76% vs -126.67% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-10.00",
          "val2": "-7.20",
          "chgp": "-38.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.40",
          "val2": "0.50",
          "chgp": "-20.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.00",
          "val2": "-6.80",
          "chgp": "-61.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-453,913.00%",
          "val2": "-203,648.60%",
          "chgp": "-25,026.44%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -80.00% vs 25.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 447.87% vs -105.77% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.50",
          "chgp": "-80.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-30.90",
          "val2": "-27.50",
          "chgp": "-12.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.30",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.30",
          "val2": "0.90",
          "chgp": "44.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "65.40",
          "val2": "-18.80",
          "chgp": "447.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-247,679.40%",
          "val2": "-55,426.40%",
          "chgp": "-19,225.30%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY

Mar'25

Mar'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-10.00

-7.20

-38.89%

Interest

0.00

0.20

-100.00%

Exceptional Items

0.40

0.50

-20.00%

Consolidate Net Profit

-11.00

-6.80

-61.76%

Operating Profit Margin (Excl OI)

-453,913.00%

-203,648.60%

-25,026.44%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2025 is 0.00% vs -100.00% in Mar 2024

Consolidated Net Profit

YoY Growth in quarter ended Mar 2025 is -61.76% vs -126.67% in Mar 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.10

0.50

-80.00%

Operating Profit (PBDIT) excl Other Income

-30.90

-27.50

-12.36%

Interest

0.20

0.30

-33.33%

Exceptional Items

1.30

0.90

44.44%

Consolidate Net Profit

65.40

-18.80

447.87%

Operating Profit Margin (Excl OI)

-247,679.40%

-55,426.40%

-19,225.30%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -80.00% vs 25.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 447.87% vs -105.77% in Dec 2023

All Annual Results

Company CV

About Scope Fluidics SA

Scope Fluidics SA

Pharmaceuticals & Biotechnology

Scope Fluidics SA is a Poland-based company engaged in the biotechnology. The Company focuses on diagnostic and med-tech solutions. It develops disposable microfluidic systems for the collection of micro-samples of blood, as well as storage of reagents for diagnostic markers. Its projects include PCR ONE system that delivers the bacterial and viral pathogen detection, and BacterOMIC system that delivers information on bacterial susceptibility to antibiotics and on the resistance mechanisms. The Company provides access to laboratories and workshops for developed projects, as well as administrative facilities and services, including financing. In addition, it cooperates with doctors, medical personnel, project managers, engineers and academics.

Company Coordinates

Company Details

Duchnicka 3, bud. 16, wejscie A , WARSZAWA None : 01-796

Tel: 48 22 3762114

http://scopefluidics.com/

Registrar Details